Author

Edward Gardner

OpenAlex ID: A5135451678

Switch to single-tablet bictegravir–lenacapavir from a complex HIV regimen (ARTISTRY-1): a randomised, open-label, phase 3 clinical trial

2026 · Chloe Orkin, Chloe Orkin, et al. · The Lancet · 5

Tecovirimat treatment of clade II mpox: a virological analysis of a randomised, double-blind, phase 3 trial

2026 · Dariia Vyshenska, Jonathan C Reed, et al. · The Lancet Microbe

Safety and efficacy of switching to bictegravir–lenacapavir versus continuing bictegravir–emtricitabine–tenofovir alafenamide in virologically suppressed people with HIV-1 (ARTISTRY-2): a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial

2026 · Eric G Meissner, Eric G Meissner, et al. · The Lancet HIV

Works count: 3

Citation count: 5

H-index: 1

I10-index: